Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123415164 | 12341516 | 4 | F | 20160428 | 20160819 | 20160506 | 20160824 | EXP | PHHY2016CR061990 | NOVARTIS | 57.00 | YR | F | Y | 0.00000 | 20160824 | CN | COUNTRY NOT SPECIFIED | CR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123415164 | 12341516 | 1 | PS | TASIGNA | NILOTINIB | 1 | Unknown | 2 DF (IN THE MORNING AT 9.30 AND AT NIGHT AT 21.30 TO 22.00 HOURS), Q12H | U | 22068 | 2 | DF | CAPSULE | Q12H | |||||
| 123415164 | 12341516 | 2 | C | INSULIN CRYSTALINE | 2 | Unknown | U | 0 | |||||||||||
| 123415164 | 12341516 | 3 | C | INSULIN | INSULIN NOS | 1 | Unknown | U | 0 | ||||||||||
| 123415164 | 12341516 | 4 | C | IRBESARTAN. | IRBESARTAN | 1 | Unknown | U | 0 | ||||||||||
| 123415164 | 12341516 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 | ||||||||||
| 123415164 | 12341516 | 6 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 123415164 | 12341516 | 7 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 123415164 | 12341516 | 8 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123415164 | 12341516 | 1 | Chronic myeloid leukaemia |
| 123415164 | 12341516 | 2 | Diabetes mellitus |
| 123415164 | 12341516 | 3 | Diabetes mellitus |
| 123415164 | 12341516 | 4 | Hypertension |
| 123415164 | 12341516 | 5 | Osteoporosis |
| 123415164 | 12341516 | 6 | Osteoporosis |
| 123415164 | 12341516 | 7 | Psoriasis |
| 123415164 | 12341516 | 8 | Thyroid disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123415164 | 12341516 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123415164 | 12341516 | Chest pain | |
| 123415164 | 12341516 | Dysarthria | |
| 123415164 | 12341516 | Ear pain | |
| 123415164 | 12341516 | Facial pain | |
| 123415164 | 12341516 | Facial paralysis | |
| 123415164 | 12341516 | Gait disturbance | |
| 123415164 | 12341516 | Hypoaesthesia oral | |
| 123415164 | 12341516 | Movement disorder | |
| 123415164 | 12341516 | Muscular weakness | |
| 123415164 | 12341516 | Nausea | |
| 123415164 | 12341516 | Neck pain | |
| 123415164 | 12341516 | Osteoporosis | |
| 123415164 | 12341516 | Pain in extremity | |
| 123415164 | 12341516 | Paraesthesia oral | |
| 123415164 | 12341516 | Vision blurred | |
| 123415164 | 12341516 | Visual impairment | |
| 123415164 | 12341516 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123415164 | 12341516 | 1 | 2014 | 0 |